AKT1 and pancreatic intraductal papillary-mucinous neoplasm: This is well illustrated in the case of IPMN versus MA, which both share the same AKT1 p.E17K mutation, which can be interpreted as supportive of merging these entities under one umbrella or as simply a case of two separate entities having the same mutation.